Please see below for a selection of interesting articles on pediatric CML in peer-reviewed journals.
Latest publications include:

• Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia
  Schleicher O et al. Front Oncol. September 2022 – open access publication
• Recent progress in the management of pediatric chronic myeloid leukemia – Review
  Shima H and Shimada H. Int J Hematol, December 2022 (epub ahead of print)
• Alterations in cellular metabolism after TKI therapy for Philadelphia chromosome-positive leukemia in children: A review
  Li C et al. Front Oncol, December 2022 – open access publication
• Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukemia treated with tyrosine kinase inhibitors
  Nishiyama-Fujita Y et al. Ann Med, December 2022 – open access publication
• Prevalence of anemia at diagnosis of pediatric chronic myeloid leukemia and prognostic impact on the disease course
  Delehaye F et al. Ann Hematol, November 2022 (epub ahead of print)
• Current childhood chronic myeloid leukemia management under tyrosine kinase inhibitor treatment
  Karadas N et al. Int J Hematol, November 2022 (epub ahead of print)
• Outcome of pediatric chronic myeloid leukemia with management focusing on gene transcript levels
  Al-Ghamlas I et al. Int J Pediatr Adolesc Med, September 2022 – open access publication
  
• Dasatinib-related pleural effusion and lymphocytosis rates are different between adult and pediatric patients with Philadelphia chromosome-positive leukemias: are age and comorbidities only to blame?
  Kiliçaslan NA et al. Expert Rev Respir Med, September 2022 (epub ahead of print)
• Secondary pseudotumor cerebri syndrome in a child with chronic myeloid leukemia: Report of a case and review of previous cases
  Rasmussen AH et al. Pediatr Blood Cancer, September 2022 (epub ahead of print)
• Management of CML in children and young adults - Review
  Ford M et al. Curr Hematol Malig Res, August 2022 (epub ahead of print) - open access publication
• Discontinuation of tyrosine kinase inhibitors based on BCR-ABL1 monitoring by digital droplet PCR in pediatric chronic myeloid leukemia
  Kim Y et al. Front Pediatr, Jul 2022 – open access publication

Search here for more publications on pediatric CML